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With rapid advances in sequencing technologies, we are undergoing a paradigm shift from
hypothesis- to data-driven research. Genome-wide proﬁling efforts have given informative
insights into biological processes; however, considering the wealth of variation, the major
challenge still remains in their meaningful interpretation. In particular sequence variation in
non-coding contexts is often challenging to interpret. Here, data integration approaches for
the identiﬁcation of functional genetic variability represent a possible solution. Exemplary,
functional linkage analysis integrating genotype and expression data determined regulatory
quantitative trait loci and proposed causal relationships. In addition to gene expression,
epigenetic regulation and speciﬁcally DNA methylation was established as highly valuable
surrogate mark for functional variance of the genetic code. Epigenetic modiﬁcation has
served as powerful mediator trait to elucidate mechanisms forming phenotypes in health
and disease. Particularly, integrative studies of genetic and DNA methylation data have
been able to guide interpretation strategies of risk genotypes, but also proved their value
for physiological traits, such as natural human variation and aging. This Review seeks to
illustrate the power of data integration in the genomic era exempliﬁed by DNA methylation
quantitative trait loci. However, the model is further extendable to virtually all traceable
molecular traits.
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INTRODUCTION
Owing to the boost in detection technologies, numerous genetic
and epigenetic variations have been related to phenotypic variabil-
ity, including human diseases. Their interpretation has given an
informative insight into aberrant biological processes and has led
to the identiﬁcation of novel targets for therapeutic interventions
(Garraway and Lander, 2013). However, considering the wealth
of alterations detectable by genome-wide studies, the major chal-
lenge still remains in the discrimination between driving events
and those that are functionally silent or mere consequence of the
disease. Furthermore, alterations frequently occur in a non-coding
context, complicating their functional interpretation (Hindorff
et al., 2011).
The comprehensive landmarking of functional elements in
the human genome provided a measure of regional transcrip-
tional activity and regulatory potential (Consortium, 2012).
Latter regions were categorized by representative histone marks,
DNA methylation levels, and chromatin conformations. How-
ever, their annotation does not immediately provide func-
tional insights, as most of regulatory loci cannot be clearly
assigned to target genes, especially those outside the pro-
moter context. Nevertheless, various studies reported a sig-
niﬁcant overlap between phenotype-associated polymorphisms
with regulatory histone marks (Hnisz et al., 2013), differentially
methylated regions (Ziller et al., 2013) or open chromatin
formations (Paul et al., 2013), suggesting their implication
in functional downstream cascades and phenotype forma-
tion.
However, despite the comprehensive functional annotation of
the human genome, we largely lack mechanistic interpretations
for the majority of genetic variations and genotype–phenotype
associations. To improve our understanding of causal relation-
ships, we need to undergo a paradigm shift from analyzing loci
function to loci effects; and shifting from annotation toward
functional linkage studies. These are in particular straightfor-
ward to interpret if a component of the associations can be
directly connected to gene function or activity. An illustrative
and well-established example of functional linkage analysis is rep-
resented by expression quantitative trait loci (eQTL), wherein
cis- or trans-located genetic polymorphisms present signiﬁcant
associations to gene activity, determined by transcript abundance
and even transcript variants (Grundberg et al., 2012; Lappalainen
et al., 2013). The identiﬁcation of direct impacts of polymor-
phisms on transcriptional activity suggests causality, with the
genetic variant and altered transcription being the cause and con-
sequence, respectively. Particularly valuable for intergenic and
intronic polymorphisms that are otherwise challenging to inter-
pret, eQTL directly point to gene targets and hence facilitate
the identiﬁcation of disease driving mechanisms (Li et al., 2010,
2013).
EPIGENETIC MEDIATOR FUNCTION IN GENE REGULATION
Functionally, the linkage model can be further extended includ-
ing mediator traits that regulate gene expression. In this regard,
virtually all regulatory events can be assigned as mediator, includ-
ing histone modiﬁcations, DNA methylation, non-coding RNAs,
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or chromatin structure. Intriguingly, although the intense inter-
play between different layers of epigenetic regulation is accepted
knowledge (Bernstein et al., 2012), it is poorly understood how the
genetic and epigenetic code interact (Schübeler, 2012).
In this respect, computational strategies linking the genome to
the epigenome, suggest a profound intrinsic association between
epigenetic marks and genetic sequence, with cumulative effects
of many weak interactions eventually forming the epigenetic
code (Yuan, 2012). Consistently, to a certain extend epigenetic
landscapes could be predicted in silico and assembled in vitro, sug-
gesting the epigenome to be partly encoded in the genome (Kaplan
et al., 2009). Herein, speciﬁcallyDNAmethylationpatterns present
strong genetic associations (Weber et al., 2005; Lienert et al., 2011).
However, the genetic blueprint is likely to permit certain epige-
netic states without precisely deﬁning shape or timing. Certainly,
the linkage between genetic variance and gene regulation could
improve our knowledge about phenotype biology and the under-
lying mechanistic chain of events. Furthermore, an integrative
analysis of genetic variation with the gene regulome could facili-
tate the interpretation of non-coding genetic variance and could
further support strategies to reliably identify phenotype driving
events.
Technically, it is important to distinguish between two con-
cepts of functional linkage studies: the analysis of overlapping
coordinates, deﬁning direct mechanistic effects (Kasowski et al.,
2010; McDaniell et al., 2010) and the deﬁnition cis-acting connec-
tions of distal elements, suggesting their regulatory relationships
(Gibbs et al., 2010; Zhang et al., 2010). While the ﬁrst is identi-
fying additional layers of regulation controlling the activity of a
speciﬁc locus (possibly being directly affected by the genetic vari-
ation; McDaniell et al., 2010; Boyle et al., 2012; Schaub et al., 2012;
Paul et al., 2013), the latter is deﬁning a sequential chain of events,
strongly suggesting functional importance. This Review will focus
on the relationship between cis-associated distal elements, as
particularly these interactions provide superior information com-
pared to on-site variation. Indeed, cis-associations not only
deﬁne local activity, but determine functionality in downstream
processes.
Despite the wealth of regulatory mechanisms, this Review
focuses on DNA methylation, as the covalent modiﬁcation of
cytosines in a CpG context presents a stable and reliably detectable
epigenetic mark with high impact on gene regulation (Jones,
2012). Generally, the DNA hypermethylation, in particular in
promoter regions, was associated to transcriptional silencing,
whereas promoter hypomethylation favors gene expression. In
contrary, the DNA methylation levels in the gene body often cor-
relate positively with transcriptional activity (Jones, 2012; Kulis
et al., 2012). Importantly from an integrative perspective, DNA
methylation levels were shown to be partially dependant on the
underlying genetic sequence deﬁned as DNA methylation quan-
titative trait loci (meQTL; Kerkel et al., 2008; Shoemaker et al.,
2010). Herein, CpG methylation levels present high correlations
with the genotype of non-overlapping nucleotides. Speciﬁcally,
DNA methylation levels appear to segregate with genotypes in
their proximity (cis-acting) rather than being farther distributed,
suggesting the contribution of the local genomic environment
to establish the connections (Shoemaker et al., 2010; Grundberg
et al., 2013; Heyn et al., 2013). Although speciﬁc mechanisms
establishing the association between the genetic and epigenetic
code are widely unknown, their identiﬁcation suggested causal
connections between genetic and epigenetic information. From
a genomic perspective, meQTL present a powerful surrogate
mark to elucidate functional and mechanistic implementations
of phenotype-associated genetic variations.
A CASCADE OF GENETIC AND EPIGENETIC REGULATION
The fact that meQTL are mainly cis-acting and located in proxim-
ity to their related epigenetic variants, suggests that local regulatory
mechanisms participate to establish the associations. A possi-
ble scenario involves distal regulative features, such as enhancer
regions, whose proximity to gene promoters is exhibited through
chromatin looping (Figure 1). Enhancer activity triggers measur-
able downstream events such as changes in transcriptional activity
or in interconnected regulatory mechanisms, including DNA
methylation. Consequently, genetic variants affecting enhancer
activity, by altering the afﬁnity of DNA binding factors (Kasowski
et al., 2010) or chromatin formation (McDaniell et al., 2010), alter
downstream cascades, detectable as epigenetic or eQTL. Impor-
tantly, these connections by themselves might deﬁne a functional
relevance of both components, determined by a traceable chain
of events. In this respect, meQTL are unlikely to represent sec-
ondary events, but rather display an important mechanism in
a causal chain that provokes variability. Consistently, meQTL
were suggested to present an intermediate regulator that medi-
ates phenotypic plasticity and providing a powerful mechanism
for evolutionary adaptation in changing environments (Feinberg
and Irizarry, 2010).
The concept of meQTL deﬁned by genome-scale data inte-
gration was initially introduced in two independent studies,
proﬁling matched genotype, epitype, and gene expression infor-
mation of brain tissue samples. Both studies, analyzed samples
from different brain regions (Gibbs et al., 2010) and cerebel-
lum (Zhang et al., 2010), respectively, determining genetically
variable loci signiﬁcantly associated to DNA methylation lev-
els at distal gene promoters. Ergo, the authors suggested a
functional and causal relationship between both levels of infor-
mation with the genetic sequence inﬂuencing DNA methylation
levels in cis or trans. Surprisingly, meQTL rarely overlapped
with eQTLs, wherein transcriptional activity correlated with the
underlying genotypes, suggesting meQTL and eQTLs as inde-
pendent features. This observation was conﬁrmed in studies
of different tissue-types that concluded a frequent dependence
of DNA methylation levels on the genetic background, how-
ever, with the majority not directly associated to expression
changes (Grundberg et al., 2013). In this regard, we suggest
interconnected DNA methylation and genetic sequence to pro-
vide a basal regulatory setting, poising genes and loci for
activation. The actual gene activity, however, can be limited
to speciﬁc cellular contexts. Consistently, a recent study inte-
grating gene expression, DNA methylation and genotype data
from three different tissue-types observed a complex relation-
ship between the three features and questioning a strict lin-
ear cause-mediator-consequence relationship (Gutierrez-Arcelus
et al., 2013).
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FIGURE 1 | Genetic variance affects the regulatory machinery.
Polymorphic alleles located in cis-regulating elements (e.g., enhancer
sites) can be associated to variation in downstream cascades resulting in
transcriptional activation (A) or silencing (B). Changes in gene regulation
can be assessed measuring variance in gene expression and related
regulatory factors, such as epigenetic modiﬁcations (e.g., DNA
methylation) or occupancy of regulatory proteins (e.g. transcription
factors).
EPIGENETIC VARIANCE FACILITATES GWAS
INTERPRETATION
In light of genome-wide association studies (GWAS),meQTL facil-
itate the interpretation of non-coding genetic variability and their
association to phenotypic differences (Freedman et al., 2011; Her-
nandez and Singleton, 2012; Kilpinen and Dermitzakis, 2012).
Recent studies have given an outlook of the potential of integra-
tive genome-epigenome studies for the meaningful interpretation
of genetic risk alleles (Gamazon et al., 2013; Scherf et al., 2013).
Further, genotype–epitype associations guided the interpretation
of physiological traits, such as natural human variation (Heyn
et al., 2013) or aging (Bell et al., 2012). Moreover, in addition to
guiding the interpretation of the genetic code, functional link-
age could, vice versa, identify epigenetic driver events from often
numerous differentially methylated regions (Liu et al., 2013). This
symbiotic liaison highlights the power of functional linkage anal-
ysis for the meaningful mining of genetic and epigenetic variance
in physiological and pathological contexts. Summarizing the cur-
rent knowledge from integrative genotype–epitype analyses, the
following examples also underscore the use of multidimensional
datasets and their power to identify phenotype driving events.
Brain associated meQTL were shown to be implemented in
neurological disease pathology and enabled the interpretation of
GWAS results derived from bipolar disorders (Gamazon et al.,
2013). Brieﬂy, polymorphic risk alleles obtained from different
genetic studies, revealed enrichment in cis-acting brain meQTL,
presenting prior unrecognized disease-related genes. Importantly,
incorporating a priori information about meQTL increased the
power of detecting genotype–phenotype associations. By restrict-
ing the analysis to cis-acting meQTL, the authors detected a
signiﬁcant association between rs12618769 and bipolar disorder,
which was not signiﬁcant in a genome-wide screening. Intrigu-
ingly, the polymorphism was associated to differences in promoter
methylation of inositol polyphosphate phosphatase 4A (INPP4A), a
gene related to the functional integrity of the brain. Thus, a data
set reduction to functionally connected variants enabled the iden-
tiﬁcation of aberrant gene regulation with possible implication in
the biology of bipolar disorders. The study presents a paradigm
of how the complexity observed in genome- and epigenome-wide
association studies can be reduced to loci with likely functional
relevance in the given context. As initial ﬁlter steps reduce the
number of required tests (which need to be corrected for in multi-
ple hypotheses testing), functionality-driven approaches might be
applicable with substantial lower sample numbers.
Following the objective to interpret GWAS, deﬁned risk vari-
ants through epigenetic data integration, another recent study
revealed differences in DNA methylation in a region previous
deﬁned as lung cancer risk locus (Scherf et al., 2013). In partic-
ular, the authors identiﬁed a signiﬁcant association of the risk
genotype with differential promoter methylation of the nico-
tinic acetylcholine receptor subunit gene CHRNA4, suggesting
a mechanistic disease-related cascade induced by the genetic
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variant. Most importantly, following the validation of a direct
association to transcriptional regulation, the authors conﬁrmed
the impact of increased CHRNA4 expression on oncogenesis
in lung tumor cells. Conclusively, the epigenetic activation of
the CHRNB4 correlated with the presence of genetically deﬁned
lung cancer susceptibility variants, suggesting a causal relation-
ship between different layers of regulation in the risk allele
biology.
Combining comprehensive geno- and epityping screening
efforts, an adipose tissue based study detected a relationship
between ametabolic disease risk loci and variantDNAmethylation
(Grundberg et al., 2013). Particularly, they determined the signif-
icant correlation between a SNP (rs713586) associated with body
mass index and DNA methylation in an enhancer region upstream
of the adenylate cyclase 3 (ADCY3), a gene previously linked to obe-
sity. Intriguingly, a SNP in perfect linkage disequilibrium directly
ﬂanking the altered CpG overlapped transcription factor binding
sites, presenting potential mechanistic consequences of the genetic
variant. Consistently, transcription factor binding was previously
shown to inﬂuence DNA methylation levels at distal regulatory
elements (Stadler et al., 2011).
EPIGENETIC VARIANCE GUIDES INTERPRETATION OF
NATURAL HUMAN VARIATION
Interestingly, the strategy of functional linkage analysis was also
proven to be informative outside the disease context using variabil-
ity observed between different individuals or human populations
(Bell et al., 2011; Fraser et al., 2012; Heyn et al., 2013; Moen
et al., 2013). Comparing three different human populations, a
blood based study determined differentially methylated CpG sites
between populations and conﬁrmed the genetic blueprint to be
the major factor determining epigenetic differences (Heyn et al.,
2013). In particular, the study detected variance in DNA methy-
lation between African, European, and Asian individuals with
potential consequences on distinct phenotypes, including differ-
ences in drug response or susceptibility to pathogen infections.
Although the variance is likely to be transmitted genetically, epige-
netically deﬁned phenotypes are exposed to the natural selection
process. Accordingly, a subset of differentially methylated genes
revealed evidence of local selection pressure. Most interestingly
from a integrative perspective, the study determined genetic vari-
ants, associated to population-speciﬁc DNA methylation, to be
enriched for SNPs previously identiﬁed as risk loci for the infec-
tion with the hepatitis B virus (HBV). Consistently, the risk SNPs
were more abundant in Asian and African individuals, ethnicities
for which the HBV infection presents an endemic disease. By inte-
grating DNA methylation data, the study determined a chain of
genetic and epigenetic events leading to variantHLA-DPA1 expres-
sion, likely to drive differences in HBV infection risk between the
populations.
Similarly, another study analyzing blood samples from donors
with African or European ancestry determined meQTL associated
with complex traits such as racial disparities (Moen et al., 2013).
In particular, an association between risk alleles for cardiovascu-
lar diseases and high cholesterol levels with differential promoter
methylation of the apolipoprotein A-V (APOA5) illustrated the
implication of meQTL in the biology of human diseases.
Conclusively, ethnicity based studies suggested DNA methyla-
tion to be an important intermediate regulator in the translational
process from geno- to phenotypes. Furthermore, it represents a
valuable information to meaningful interpret variability observed
between populations, however, also proving its value to explain
inter-individual variation.
GENETIC LINKAGE IDENTIFIES EPIGENETIC DRIVER EVENTS
Likely, the genetic code vice versa serves as an anchor point to
extract functional important epigenetic variation fromhighly vari-
ant epigenomes. Considering the numerous epigenetic events in
cancer, wherein multiple genes simultaneously gain or lose DNA
methylation, the identiﬁcation of epigenetic drivers presents an
extremely difﬁcult task. However, connecting DNA methylation
data to additional layers of information, such as genotype or
gene expression, suggests interconnected epigenetic events that
are more likely to be of functional importance than unconnected
alterations. In this regard, genetic connections could be of value to
separate epigenetic driver from passenger events, and to simulta-
neously deﬁne novel risk genotypes and functional cancer genes.
Herein, epitype–genotype associations represent a role-model
for the interplay between different cellular mechanisms, whose
interpretation will certainly provide a rich resource for disease
biomarkers and strategic nodes for therapeutic intervention.
The concept of data integration for the meaningful interpre-
tation of genome-scale DNA methylation data was successfully
applied using meQTL to determine functional epigenetic events
and novel genetic risk loci in rheumatoid arthritis patients
(Liu et al., 2013). Speciﬁcally, the study determined differen-
tially methylated CpG sites between patients and controls, and
subsequently assessed potential genetic risk loci based on their
association to aberrantly methylated CpG sites. Deﬁning genotype
as causal factor, DNA methylation as mediator and the disease as
outcome, the authors assumed direct relationships between these
features, which enabled the identiﬁcation of genetic risk polymor-
phism and their underlying chain of events leading to rheumatoid
arthritis. In particular, the authors deﬁned several signiﬁcant
associations located within the major histocompatibility complex
(MHC), genes previously related to disease risk to rheumatoid
arthritis. In addition, the study identiﬁed DNA methylation levels
of the glutathione S-transferase alpha 2 (GSTA2) promoter region
to be under genetic control. In line with the results, genetic vari-
ance in GSTA2 family members, such as GSTT1, GSTM1 and
GSTP1, have been previously reported to predict arthritis risk and
severity.
Using an integrative approach, the authors identiﬁed novel
genetic risk variants. The strategy also enabled them to distin-
guish disease driving epigenetic events from those that might have
been a consequence of the disease itself. Thus, assuming a causal
relationship between the genetic and epigenetic code, functional
linkage analysis is applicable for the simultaneous identiﬁcation
of genetic and epigenetic disease-driving events.
INTEGRATIVE PRODUCTION PIPELINES IN INTERNATIONAL
CONSORTIA
Highlighting the informative value of associations between the
genotype and epigenetic regulation, this Review aimed to illustrate
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the power of data integration in the genomic era. Although pre-
senting important information itself, genotype data only reveals
its real potential after determining its interaction within the cel-
lular context. Herein, phenotype relationships detected in GWA
studies only deﬁne the endpoint in a network of intensively cross-
linked cascades of events; and it is in particular their identiﬁcation
that enables a meaningful interpretation of signiﬁcant statistical
connections. Hence, considering currently ongoing massive data
production efforts, we suggest a high value for the simultaneous
screening of multiple layers of cellular information. In addition
to providing important information for their respective research
ﬁelds, their integration in multidimensional analysis pipelines will
further improve meaningful readouts. Eventually, combined data
fromdifferent sources of informationwill providemore value than
the sum of its individual components.
In view of the presented examples, we encourage international
multidisciplinary research consortia to continue their strategies
aiming to comprehensively proﬁle all aspects of the human
genome. Although the need for simultaneous production of
different data types is widely accepted and moved forward in con-
sortia like the International Cancer Genome Consortium (ICGC,
icgc.org), integrative analysis pipelines are still immature and stan-
dards still remain elusive. However, ﬁrst computational tools for
the integration of genotype data are developed and freely available
to the broad research community (He et al., 2013; Zhang et al.,
2014).
Moreover, signiﬁcant associations between different layers of
information need to be annotated in common portals with open
access for the community. While this has been partially achieved
for genotype-expression associations (He et al., 2013), novel com-
ponents could amplify the information provided, in order to
improve our understanding of complex cellular connections and
disease biology.
The association of DNA methylation and genetic sequence dis-
plays an exemplary application, which is further extendable to
virtually all traceable cellular features, including proteomics or
metabolomics, among many others. It will be the knowledge
of these complex relationships that will drive future efforts to
resolve the conundrum of human variation in physiological and
pathological contexts.
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